Roland Sackers - QIAGEN NV Managing Director

QIA Stock  EUR 43.86  0.19  0.44%   

Managing Director

Mr. Roland Sackers has served as Managing Director, Chief Financial Officer, Member of the Executive Committee of Qiagen N.V. since 2016. He joined the Company in 1999 as Vice President Finance and was Chief Financial Officer since 2004. In 2006, Mr. Sackers became a member of the Managing Board. Between 1995 and 1999, he served as an auditor with Arthur Andersen Wirtschaftsprfungsgesellschaft Steuerberatungsgesellschaft. Mr. Sackers earned his Master Degree Business Administration from Westfaelische WilhelmsUniversitaet Muenster. He is a former member of the Supervisory Board and Audit Committee of IBS AG and a former member of the board of directors of Operon Biotechnologies, Inc since 2016.
Age 51
Tenure 8 years
Sackers is a board member of the industry association BIO Deutschland. He is also a nonexecutive director and chair of the audit committee of Immunodiagnostic Systems Holding PLC, a producer of immunological tests for research and diagnostic applications publicly listed in the United Kingdom.
QIAGEN NV (QIA) is traded on Berlin Exchange in Germany and employs 22 people.

QIAGEN NV Leadership Team

Elected by the shareholders, the QIAGEN NV's board of directors comprises two types of representatives: QIAGEN NV inside directors who are chosen from within the company, and outside directors, selected externally and held independent of QIAGEN. The board's role is to monitor QIAGEN NV's management team and ensure that shareholders' interests are well served. QIAGEN NV's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, QIAGEN NV's outside directors are responsible for providing unbiased perspectives on the board's policies.
Metin Colpan, Independent Member of the Supervisory Board
Stephane Bancel, Independent Member of the Supervisory Board
Hakan Bjorklund, Independent Chairman of the Supervisory Board
Thierry Bernard, Chief Executive Officer, Senior Vice President - Molecular Diagnostics Business Area, Member of the Executive Committee
Toralf Haag, Member of the Supervisory Board
Elaine Mardis, Independent Member of the Supervisory Board
Ross Levine, Independent Member of the Supervisory Board
Thomas Ebeling, Member of the Supervisory Board
Roland Sackers, Managing Director, Chief Financial Officer, Member of the Executive Committee
Elizabeth Tallett, Independent Member of the Supervisory Board
Lawrence Rosen, Independent Chairman of the Supervisory Board

QIAGEN Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is QIAGEN NV a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in QIAGEN Stock

When determining whether QIAGEN NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of QIAGEN NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Qiagen Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Qiagen Nv Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in QIAGEN NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade QIAGEN Stock refer to our How to Trade QIAGEN Stock guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Please note, there is a significant difference between QIAGEN NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if QIAGEN NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, QIAGEN NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.